Altogether, these results strongly suggest that a combination of ALK and autophagy inhibition could be beneficial for the treatment of ALK-dependent ALCL, a therapeutic combination that has never been considered before. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.